Direct-Acting Antivirals Cure Innate Immunity in Chronic Hepatitis C

Gastroenterology

Volumn 149, Issue 1, 2015, Pages 25-28

  Mondelli, Mario U ^a,b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; ASUNAPREVIR; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; DACLATASVIR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; RIBAVIRIN; STAT1 PROTEIN; STAT4 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADAPTIVE IMMUNITY; APOPTOSIS; CD8+ T LYMPHOCYTE; CELL CYCLE ARREST; CYTOKINE RELEASE; CYTOTOXICITY; DNA POLYMORPHISM; EDITORIAL; GENOTYPE; HEPATITIS C; HUMAN; IMMUNOSURVEILLANCE; INNATE IMMUNITY; LONG TERM EXPOSURE; LYMPHOID CELL; MICROENVIRONMENT; NATURAL KILLER CELL; PRIORITY JOURNAL; STELLATE CELL; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRAL CLEARANCE; VIRUS REPLICATION; DRUG EFFECTS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; IMMUNOLOGY; MALE;

ANTIVIRAL AGENTS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; KILLER CELLS, NATURAL; MALE; RIBAVIRIN;

EID: 84931296836     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.05.026     Document Type: Editorial

References (23)

1. E. Serti, X. Chepa-Lotrea, and Y.J. Kim Successful Interferon-free therapy of chronic hepatitis C virus infection normalizes natural killer cell function Gastroenterology 149 2015 190 200
2. L. Golden-Mason, and H.R. Rosen Natural killer cells: multifaceted players with key roles in hepatitis C immunity Immunol Rev 255 2013 68 81
3. B. Rehermann Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells Nat Med 19 2013 859 868
4. M.L. Shiffmann, and Y. Benhamou Cure of HCV related liver disease Liver Int 35 2015 S71 S77
5. D.E. Kaplan, K. Sugimoto, and F. Ikeda T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C Hepatology 41 2005 1365 1375
6. T. Pembroke, I. Rees, and K. Gallagher Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity Eur J Immunol 42 2012 2383 2394
7. D.G. Doherty, and C. O'Farrelly Innate and adaptive lymphoid cells in the human liver Immunol Rev 174 2000 5 20
8. G. Ahlenstiel, B. Edlich, and L.J. Hogdal Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C Gastroenterology 141 2011 1231 1239
9. B. Edlich, G. Ahlenstiel, and A. Zabaleta Azpiroz Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients Hepatology 55 2012 39 48
10. B. Oliviero, D. Mele, and E. Degasperi Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection J Hepatol 59 2013 38 44
11. B. Oliviero, S. Varchetta, and E. Paudice Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections Gastroenterology 137 2009 1151 1160
12. G. Ahlenstiel, R.H. Titerence, and C. Koh Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner Gastroenterology 138 2010 325 335
13. T. Miyagi, T. Takehara, and K. Nishio Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection J Hepatol 53 2010 424 430
14. G. Missale, M. Pilli, and A. Zerbini Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection Gut 61 2012 1076 1084
15. S. Varchetta, D. Mele, and S. Mantovani Impaired intrahepatic natural killer cell function in chronic hepatitis C virus infection Hepatology 56 2012 841 849
16. E.B. Wilson, D.H. Yamada, and H. Elsaesser Blockade of Chronic type I interferon signaling to control persistent LCMV infection Science 340 2013 202 207
17. J.R. Teijaro, C. Ng, and A.M. Lee Persistent LCMV infection is controlled by blockade of type I interferon signaling Science 340 2013 207 211
18. L.G. Guidotti, and F.V. Chisari Noncytolytic control of viral infections by the innate and adaptive immune response Annu Rev Immunol 19 2001 65 91
19. P. Korkodelis, B. Krämer, and C. Körner An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients Hepatology 59 2014 814 827
20. B. Martin, N. Hennecke, and V. Lohmann Restoration of HCV-specific CD8+ T cell function by interferon-free therapy J Hepatol 61 2014 538 543
21. P.B. Sugden, B. Cameron, and M. Mina Protection against hepatitis C infection via NK cells in highly-exposed uninfected injecting drug users J Hepatol 61 2014 738 745
22. B. Gao, and S. Radaeva Natural killer and natural killer T cells in liver fibrosis Biochim Biophys Acta 1832 2013 1061 1069
23. R. D'Ambrosio, A. Aghemo, and M.G. Rumi A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis Hepatology 56 2012 532 543